Eosinophils and itch: Partners in crime or strange bedfellows?

Slides:



Advertisements
Similar presentations
Advances in rhinitis and rhinosinusitis in 2015
Advertisements

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases 
Natalija Novak, MD  Journal of Allergy and Clinical Immunology 
Fatty acids, inflammation, and asthma
Seema S. Aceves, MD, PhD  Journal of Allergy and Clinical Immunology 
Advances in food allergy in 2015
Neurovascular Aspects of Skin Neurogenic Inflammation
Diagnosis and management of anaphylaxis in precision medicine
Fanny Legrand, PhD, PharmD, Amy D. Klion, MD 
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Current application of exhaled nitric oxide in clinical practice
Therapeutic pipeline for atopic dermatitis: End of the drought?
Is 9 more than 2 also in allergic airway inflammation?
Severe asthma: Advances in current management and future therapy
Fatty acids, inflammation, and asthma
Inflammation of small airways in asthma
Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions  Shelley F. Stone, PhD, Claire Cotterell,
Silvana Balzar, MD, Matthew Strand, PhD, Diane Rhodes, PhD, Sally E
The Editors' Choice Journal of Allergy and Clinical Immunology
Advances in rhinitis and rhinosinusitis in 2015
The National Biome Initiative: An allergy perspective
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria  Tse Wen Chang, PhD, Christina Chen, BS, Chien-Jen.
Recapitulating Atopic Dermatitis in Three Dimensions: Cross Talk between Keratinocytes and Nerve Fibers  Carlo Pincelli, Martin Steinhoff  Journal of.
Omar Tliba, PhD, DVM, Reynold A. Panettieri, MD 
Asthma treatment and asthma prevention: A tale of 2 parallel pathways
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells  Zoulfia Allakhverdi, PhD, Michael R. Comeau,
Aspirin-induced asthma: Advances in pathogenesis and management
A survivor: The eosinophil as a regulator in asthma
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Early decreases in blood eosinophil levels with reslizumab
Charles E. Reed, MD, Hirohito Kita, MD 
Pathophysiology of the inflammatory response
News & Notes Journal of Allergy and Clinical Immunology
The immunopharmacology of mild asthma
James J. Lee, PhD, Cheryl A. Protheroe, BA, Huijun Luo, PhD, Sergei I
The role of the mast cell in the pathophysiology of asthma
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
The role of the T cell in asthma
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Mast cell granules: Modulating adaptive immune response remotely
Lora G. Bankova, MD, Joshua A. Boyce, MD 
The eosinophil—quo vadis?
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Nervous elements influencing intestinal inflammation and rotavirus diarrhea may lead to new treatments  Dan Gordon  Gastroenterology  Volume 118, Issue.
Pathogenesis of allergic rhinitis
New pathways for itching in patients with atopic dermatitis?
Sachin K. Samuchiwal, PhD, Joshua A. Boyce, MD 
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness  Michael R. Edwards, PhD, Katherine Strong,
The Editors' Choice Journal of Allergy and Clinical Immunology
Anaphylaxis Journal of Allergy and Clinical Immunology
Esophageal eosinophilia caused by milk proteins: From suspicion to evidence based on 2 case reports  Soledad Terrados Cepeda, MD, Dario Antolin-Amerigo,
Anaphylaxis, killer allergy: Long-term management in the community
Clinical and pathologic perspectives on aspirin sensitivity and asthma
Endotoxin and the lung: Insight into the host-environment interaction
Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics  Debajyoti Ghosh, PhD, Jonathan A. Bernstein,
Immune pathomechanism of drug hypersensitivity reactions
Allergic fungal sinusitis: An immunohistologic analysis
The Editors' Choice Journal of Allergy and Clinical Immunology
News & Notes Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010  Scott H. Sicherer, MD, Donald Y.M.
Itching as a systemic disease
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Eosinophils and itch: Partners in crime or strange bedfellows? Kristin M. Leiferman, MD  Journal of Allergy and Clinical Immunology  Volume 135, Issue 2, Pages 488-490 (February 2015) DOI: 10.1016/j.jaci.2014.11.036 Copyright © 2015 Terms and Conditions

Fig 1 Eosinophils, mast cells and itch. Eosinophils (Eos) and mast cells (MC) both have described associations with C-type nerve fibers implicated with itch. C-polymodel (CPm) fibers are activated in the epidermis through protease-activated receptor 2 (PAR-2), of which mast cell tryptase is an agonist; PAR-2 appears to mediate cutaneous itch directly through a histamine-independent mechanism. Furthermore, histamine released by mast cells activates C-mechanically insensitive (CMi) fibers that innervate widespread areas of the skin and, on activation, release proinflammatory mediators that lead to vasodilatation. Therefore activated mast cells exhibit effects on both types of C-fibers that contribute to itch and inflammation.11 Relationships between eosinophils and nerves are broadly known, but the effects of eosinophils on nerve activation related to itch are not as directly understood as are the effects of mast cells. Eosinophils synthesize neurotrophins, including nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3. Eosinophils localize to the skin in mouse models near increased nerves, and eosinophils in culture with nerves cause branching of sensory neurons. Eosinophil granule proteins block neuronal M2 muscarinic receptors, possibly contributing to airways hypersensitivity in asthmatic patients. Eosinophils and mast cells interact to enhance nerve activation, perhaps synergistically both through effects on nerves and effects on each other. If mast cell numbers, activation state, or both are decreased in the absence of eosinophils, then the mast cell contribution to itch and inflammation (and edema and tissue remodeling) will be decreased. The relative contributions of eosinophils and mast cells in this situation cannot be assessed specifically unless mast cells are taken out of the picture. Indirectly, they could be assessed if mast cell numbers and activation products were compared with the reaction parameters both in the presence and absence of eosinophils. Journal of Allergy and Clinical Immunology 2015 135, 488-490DOI: (10.1016/j.jaci.2014.11.036) Copyright © 2015 Terms and Conditions